Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Pfizer discovers potent, selective beta3-adrenoceptor full agonist

April 22, 1997

Astra Arcus develops selective CCK-A agonist with potential for obesity

April 22, 1997

First launch for Lipobay

April 22, 1997

ACAT inhibitors from Nihon Nohyaku

April 22, 1997

Cholesterol biosynthesis inhibitors described by Nippon Soda

April 21, 1997

Teijin and Microbial Chemistry Research Foundation reveal acetyl-CoA carboxylase inhibitor

April 21, 1997

Novavax completes phase Ia trial of generic human testosterone drug

April 21, 1997

Antidiabetic coumarin derivatives from Otsuka

April 21, 1997

Alteon reports positive results from phase II trials with pimagedine

April 18, 1997

Atorvastatin available in Germany for hyperlipidemia

April 18, 1997

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...